Showing results (71-80 of 217) with videos related to
Sort By:
Pageof 22
The Lancet. Psychiatry|January 23, 2025
Comparative effectiveness of antipsychotic treatment strategies for relapse prevention in first-episode schizophrenia in Finland: a population-based cohort studyHeidi Taipale, Antti Tanskanen, Oliver Howes, et al.Journal of Psychopharmacology (Oxford, England)|August 22, 2018
The effects of haloperidol on microglial morphology and translocator protein levels: An in vivo study in rats using an automated cell evaluation pipelinePeter S Bloomfield, David Bonsall, Lisa Wells, et al.Current Pharmaceutical Design|October 2, 2014
The role of white matter abnormalities in treatment-resistant depression: a systematic reviewGianluca Serafini, Maurizio Pompili, Stefan Borgwardt, et al.Annals of General Psychiatry|December 30, 2025
Managing schizophrenia with affective, sexual, metabolic and substance-use comorbidities: pharmacological considerations from an expert consensusEduard Vieta, Ángel L Montejo, Toby Pillinger, et al.BMJ Open|May 13, 2021
Acute psychological impact of coronavirus disease 2019 outbreak among psychiatric professionals in China: a multicentre, cross-sectional, web-based studyXin Guo, Robert McCutcheon, Toby Pillinger, et al.The British Journal of Psychiatry : the Journal of Mental Science|July 14, 2026
Applying immunity and metabolism to psychiatry: lost, or in translation?Riccardo De Giorgi, Margaret K Hahn, Thomas Cheliotis-James, et al.Schizophrenia Bulletin|January 5, 2018
Defining the Locus of Dopaminergic Dysfunction in Schizophrenia: A Meta-analysis and Test of the Mesolimbic HypothesisRobert McCutcheon, Katherine Beck, Sameer Jauhar, et al.Psychological Medicine|June 17, 2026
Real-world effectiveness of antipsychotic treatment of functional outcomes over 10 years: A national cohort of patients in Denmark with schizophreniaRicardo Twumasi, Frederikke Hørdam Gronemann, Carsten Hjorthøj, et al.IEEE Transactions on Bio-Medical Engineering|October 12, 2018
A Unified Framework for Plasma Data Modeling in Dynamic Positron Emission Tomography StudiesMatteo Tonietto, Gaia Rizzo, Mattia Veronese, et al.European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|October 26, 2019
Glutamatergic function in a genetic high-risk group for psychosis: A proton magnetic resonance spectroscopy study in individuals with 22q11.2 deletionMaria Rogdaki, Pamela Hathway, Maria Gudbrandsen, et al.Pageof 22